Clinicopathological study of Japanese patients with genetic iron overload syndromes

被引:21
|
作者
Hattori, Ai [1 ,2 ]
Miyajima, Hiroaki [3 ]
Tomosugi, Naohisa [4 ]
Tatsumi, Yasuaki
Hayashi, Hisao
Wakusawa, Shinya [2 ]
机构
[1] Aichi Gakuin Univ, Sch Pharm, Dept Med, Chikusa Ku, Nagoya, Aichi 4648650, Japan
[2] Nagoya Univ, Grad Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi 4648601, Japan
[3] Hamamatsu Univ Sch Med, Dept Internal Med 1, Hamamatsu, Shizuoka 4313192, Japan
[4] Kanazawa Med Univ, Dept Nephrol, Kanazawa, Ishikawa, Japan
关键词
aceruloplasminemia; ferroportin; hemochromatosis; hepcidin; HEREDITARY HEMOCHROMATOSIS; HFE GENE; JUVENILE HEMOCHROMATOSIS; CHRONIC HEPATITIS; LIVER-DISEASE; HEART-DISEASE; MUTATIONS; HEPCIDIN; FERROPORTIN; TFR2;
D O I
10.1111/j.1440-1827.2012.02848.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In addition to hemochromatosis, aceruloplasminemia and ferroportin disease may be complicated by iron-induced multiple organ damage. Therefore, clinicopathological features should be evaluated in a wider range of genetic iron disorders. This study included 16 Japanese patients with genetic iron overload syndromes. The responsible genes were CP in four, HAMP in one, HJV in three, TFR2 in five, and SLC40A1 in three patients. No phenotype dissociation was observed in patients with the CP, TFR2, or HAMP genotypes. Two of the three patients with the HJV genotype displayed classic hemochromatosis instead of the juvenile type. Patients with the SLC40A1 genotype were affected by mild iron overload (ferroportin A) or severe iron overload (ferroportin B). Transferrin saturation was unusually low in aceruloplasminemia patients. All patients, except those with ferroportin disease, displayed low serum hepcidin-25 levels. Liver pathology showed phenotype-specific changes; isolated parenchymal iron loading in aceruloplasminemia, periportal fibrosis associated with heavy iron overload in both parenchymal and Kupffer cells of ferroportin B, and parenchyma-dominant iron-loading cirrhosis in hemochromatosis. In contrast, diabetes occurred in all phenotypes of aceruloplasminemia, hemochromatosis, and ferroportin disease B. In conclusion, clinicopathological features were partially characterized in Japanese patients with genetic iron overload syndromes.
引用
收藏
页码:612 / 618
页数:7
相关论文
共 50 条
  • [1] A NEW CLASSIFICATION OF GENETIC IRON OVERLOAD SYNDROMES
    Yano, Motoyoshi
    Miyajima, Hiroaki
    Tomosugi, Naohisa
    Wakusawa, Shinya
    Yamashita, Tetsuji
    Hattori, Ai
    Tatsumi, Yasuaki
    Kato, Koichi
    Hayashi, Hisao
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E203 - E203
  • [2] Iron overload in patients with myelodysplastic syndromes
    Jensen P.-D.
    Current Hematologic Malignancy Reports, 2007, 2 (1) : 13 - 21
  • [3] Genetic background of primary iron overload syndromes in Japan
    Hayashi, Hisao
    Wakusawa, Shinya
    Motonishi, Satoshi
    Miyamoto, Ken-ichi
    Okada, Hidetoshi
    Inagaki, Yasutaka
    Ikeda, Takaaki
    INTERNAL MEDICINE, 2006, 45 (20) : 1107 - 1111
  • [4] SYNDROMES OF IRON OVERLOAD
    ALRASHID, RA
    CLINICAL TOXICOLOGY, 1971, 4 (04) : 571 - +
  • [5] IRON OVERLOAD SYNDROMES
    POLLYCOVE, M
    CLINICAL PHYSIOLOGY AND BIOCHEMISTRY, 1986, 4 (01) : 61 - 77
  • [6] Iron-overload links to genetic instability in myelodysplastic syndromes
    Westhofen, G.
    Ganster, C.
    Beyer, F.
    Rassaf, T.
    Al-Ali, H. K.
    Stuhlmann, R.
    Glass, B.
    Bacher, U.
    Bruemmendorf, T.
    Germing, U.
    Gattermann, N.
    Haase, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 123 - 123
  • [7] Iron overload-induced genetic instability in myelodysplastic syndromes
    Westhofen, G.
    Ganster, C.
    Al-Ali, H. K.
    Haase, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 248 - 249
  • [8] A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes
    Cermak, Jaroslav
    Jonasova, Anna
    Vondrakova, Jana
    Cervinek, Libor
    Belohlavkova, Petra
    Neuwirtova, Radana
    LEUKEMIA RESEARCH, 2013, 37 (12) : 1612 - 1615
  • [9] Iron Overload in Patients With Myelodysplastic Syndromes: An Updated Overview
    Moukalled, Nour M.
    El Rassi, Fuad A.
    Temraz, Sally N.
    Taher, Ali T.
    CANCER, 2018, 124 (20) : 3979 - 3989
  • [10] Impact of Management of Iron Overload in Patients with Myelodsplastic Syndromes
    Bozkaya, Duycu
    Migliaccio-Walle, Kristen
    Baladi, Jean-Francois
    BLOOD, 2008, 112 (11) : 473 - 473